These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2164624)

  • 21. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
    Jansson LM; Dipietro JA; Elko A; Velez M
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal abstinence syndrome: strategies for care of the drug-exposed infant.
    Greene CM; Goodman MH
    Neonatal Netw; 2003; 22(4):15-25. PubMed ID: 12934746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals.
    Stanton ME; Spear LP
    Neurotoxicol Teratol; 1990; 12(3):261-7. PubMed ID: 2115099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; Germain AM; Brooks SS; Cline GJ; Clark L
    Neonatal Netw; 2016; 35(5):277-86. PubMed ID: 27636691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Substance abuse and pregnancy: narcotics--selected problems].
    Wilczyński J; Hincz P; Nadel I
    Ginekol Pol; 1997 Apr; 68(4):206-12. PubMed ID: 9463086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
    Hoell I; Havemann-Reinecke U
    Med Monatsschr Pharm; 2011 Oct; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal Exposure and Neonatal Effects of Drugs of Abuse.
    Barry JM; Birnbaum AK; Jasin LR; Sherwin CM
    J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S142-S155. PubMed ID: 34396555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
    Bhatt-Mehta V; Ng CM; Schumacher RE
    Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone and buprenorphine treatment during pregnancy: what are the effects on infants?
    Pritham UA; Troese M; Stetson A
    Nurs Womens Health; 2007 Dec; 11(6):558-67. PubMed ID: 18088293
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drugs and pregnancy].
    Halmesmäki E; Kari A
    Duodecim; 1998; 114(20):2109-14. PubMed ID: 11717737
    [No Abstract]   [Full Text] [Related]  

  • 33. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behaviour in first year after drug dependent pregnancy.
    van Baar AL; Fleury P; Ultee CA
    Arch Dis Child; 1989 Feb; 64(2):241-5. PubMed ID: 2930229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal.
    Doberczak TM; Kandall SR; Friedmann P
    Obstet Gynecol; 1993 Jun; 81(6):936-40. PubMed ID: 8497359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal abstinence syndrome and the gastrointestinal tract.
    Maguire D; Gröer M
    Med Hypotheses; 2016 Dec; 97():11-15. PubMed ID: 27876117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-exposed infants. American Academy of Pediatrics Committee on Substance Abuse.
    Pediatrics; 1995 Aug; 96(2 Pt 1):364-7. PubMed ID: 7630703
    [No Abstract]   [Full Text] [Related]  

  • 38. Substance abuse during pregnancy.
    Wheeler SF
    Prim Care; 1993 Mar; 20(1):191-207. PubMed ID: 8464941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The temporal influence of a heroin shortage on pregnant drug users and their newborn infants in Sydney, Australia.
    Pong KM; Abdel-Latif ME; Lui K; Wodak AD; Feller JM; Campbell T; Oei J
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):230-6. PubMed ID: 20618239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of in-utero opiate exposure: new paradigms for old questions.
    Kaltenbach KA
    Drug Alcohol Depend; 1994 Oct; 36(2):83-7. PubMed ID: 7851284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.